InterCure Ltd.

NASDAQ: INCR · Real-Time Price · USD
1.66
0.00 (0.00%)
At close: Aug 15, 2025, 12:28 PM

InterCure Cash Flow Statement

Financials in ILS. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-72.79M -63.53M 43.75M 7.29M
Depreciation & Amortization
15.37M 13.17M 11.7M 7.39M
Stock-Based Compensation
2.28M 2.59M 8.91M 6.45M
Other Working Capital
3.88M -12.63M 34.22M 5.06M
Other Non-Cash Items
11.94M 35.44M -10.16M -5.91M
Deferred Income Tax
-14.53M 2.25M 93K 11.44M
Change in Working Capital
-9.19M -43.55M -3.02M -1.65M
Operating Cash Flow
-66.93M -53.63M 51.27M 25.02M
Capital Expenditures
-4.38M -2.62M -19.74M -14.03M
Cash Acquisitions
405K -4.2M -8.32M -19.09M
Purchase of Investments
n/a n/a n/a -1.25M
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
21.66M 11.59M -114.44M -30.84M
Investing Cash Flow
17.69M 4.77M -142.5M -65.21M
Debt Repayment
7.74M -61.98M 137.73M 65.83M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-15.29M -20.91M -17.28M 3.38M
Financial Cash Flow
26.45M -82.89M 120.45M 203.06M
Net Cash Flow
-22.82M -131.45M 36.37M 158.33M
Free Cash Flow
-71.3M -56.25M 31.52M 10.99M